Skip to main content

Table 7 Adverse events and side effects

From: Oral mosapride can provide additional anti-emetic efficacy following total joint arthroplasty under general anesthesia: a randomized, double-blinded clinical trial

 

Control

(n = 80)

Dexa

(n = 82)

Mosa + Dexa

(n = 78)

p*

Long QT syndrome

0

0

0

NA

Diarrhea

0

1 (1.22%)

0

1.000

Abdominal pain

1 (1.25%)

0

1 (1.28%)

0.556

Dry mouth

2 (2.5%)

1 (1.22%)

2 (2.56%)

0.752

Insomnia

2 (2.5%)

3 (3.66%)

3 (3.85%)

0.908

Total

5 (6.25%)

5 (6.1%)

6 (7.69%)

0.906

  1. Data presented as mean ± standard deviation. Dexa dexamethasone; Mosa mosapride
  2. *p values were analyzed using Fisher’s exact test
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us